Literature DB >> 28937873

Effect of parathyroidectomy on osteopontin and undercarboxylated osteocalcin in patients with primary hyperparathyroidism.

Raelene E Maser1,2, M James Lenhard2,3, Ryan T Pohlig4, P Babu Balagopal5, Raafat Abdel-Misih6.   

Abstract

PURPOSE: Surgical treatment for primary hyperparathyroidism (PHPT) improves bone metabolism. Osteocalcin (OC) and its undercarboxylated form (ucOC) are associated with bone and energy metabolism. Osteopontin (OPN), a multifunctional protein expressed in bone, is involved in resorption, along with β-carboxyl-terminal cross-linking telopeptide of type 1 collagen (β-CTX), and osteoprotegerin (OPG). Our aim was to investigate these biomarkers of bone metabolism in patients with PHPT.
METHODS: We examined 30 individuals with PHPT, in a clinical research facility, before and 1 month following parathyroidectomy. Circulating levels of OC, ucOC, OPN, β-CTX, and OPG were examined as bone biomarkers along with inflammatory markers (e.g., interleukin-6 [IL-6], lipocalin-2), insulin resistance (i.e., homeostasis model assessment for insulin resistance [HOMA-IR]), adiposity (i.e., leptin, adiponectin), PTH, calcium, 25-hydroxyvitamin D, creatinine, and demographics.
RESULTS: Participants (27 females/3 males) were 60 ± 9 (mean±SD) years old. There was a significant reduction of ucOC (7.9 ± 5.1 [median±SIQR] vs. 6.6 ± 3.7 ng/mL, p = 0.022) and OPN (75.4 ± 14.5 vs. 54.5 ± 9.2 ng/mL, p < 0.001) pre- versus post-parathyroidectomy. There were no univariate differences postoperatively for IL-6, HOMA-IR, leptin, or adiponectin. Regression analysis showed that postoperative levels of adiponectin, IL-6, and OPN were significantly associated with ucOC, while adjusting for PTH and albumin corrected calcium levels (model R2 = 0.610, p = 0.001). With OPN as the dependent variable, higher adiponectin and lower ucOC were significantly associated with lower OPN levels postoperatively (model R2 = 0.505, p = 0.010).
CONCLUSION: The lower 1-month postoperative OPN and ucOC levels in PHPT seem to indicate reduced bone resorption. Decreased ucOC levels may also suggest lower energy demands postoperatively.

Entities:  

Keywords:  Osteopontin; parathyroidectomy; primary hyperparathyroidism; undercarboxylated osteocalcin

Mesh:

Substances:

Year:  2017        PMID: 28937873      PMCID: PMC6082020          DOI: 10.1080/07435800.2017.1369432

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  33 in total

Review 1.  An overview of osteocalcin progress.

Authors:  Jinqiao Li; Hongyu Zhang; Chao Yang; Yinghui Li; Zhongquan Dai
Journal:  J Bone Miner Metab       Date:  2016-01-08       Impact factor: 2.626

2.  Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy.

Authors:  P Christiansen; T Steiniche; K Brixen; I Hessov; F Melsen; L Heickendorff; L Mosekilde
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

Review 3.  Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength.

Authors:  Paul J Kostenuik
Journal:  Curr Opin Pharmacol       Date:  2005-09-26       Impact factor: 5.547

4.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Authors:  S K Lee; J A Lorenzo
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

5.  Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation.

Authors:  Keiichiro Kitahara; Muneaki Ishijima; Susan R Rittling; Kunikazu Tsuji; Hisashi Kurosawa; Akira Nifuji; David T Denhardt; Masaki Noda
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

Review 6.  OPN -Revisited.

Authors:  Vijayanirmala Subraman; Muthukumar Thiyagarajan; N Malathi; Sharada T Rajan
Journal:  J Clin Diagn Res       Date:  2015-06-01

7.  Interleukin-6 production and secretion by human parathyroids.

Authors:  S A Safley; F Villinger; E H Jackson; C Tucker-Burden; C Cohen; C J Weber
Journal:  Clin Exp Immunol       Date:  2004-04       Impact factor: 4.330

Review 8.  Bone: from a reservoir of minerals to a regulator of energy metabolism.

Authors:  Cyrille B Confavreux
Journal:  Kidney Int Suppl       Date:  2011-02-23       Impact factor: 10.545

9.  Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.

Authors:  Nicolas Verheyen; Astrid Fahrleitner-Pammer; Evgeny Belyavskiy; Martin R Gruebler; Hans Peter Dimai; Karin Amrein; Klemens Ablasser; Johann Martensen; Cristiana Catena; Elisabeth Pieske-Kraigher; Caterina Colantonio; Jakob Voelkl; Florian Lang; Ioana Alesutan; Andreas Meinitzer; Winfried März; Helmut Brussee; Burkert Pieske; Stefan Pilz; Andreas Tomaschitz
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

Review 10.  The potential of lipocalin-2/NGAL as biomarker for inflammatory and metabolic diseases.

Authors:  Vanessa Abella; Morena Scotece; Javier Conde; Rodolfo Gómez; Ana Lois; Jesús Pino; Juan J Gómez-Reino; Francisca Lago; Ali Mobasheri; Oreste Gualillo
Journal:  Biomarkers       Date:  2015-12-15       Impact factor: 2.658

View more
  1 in total

1.  Vitamin K-Dependent Carboxylation of Osteocalcin in Bone-Ally or Adversary of Bone Mineral Status in Rats with Experimental Chronic Kidney Disease?

Authors:  Marta Ziemińska; Dariusz Pawlak; Beata Sieklucka; Katarzyna Chilkiewicz; Krystyna Pawlak
Journal:  Nutrients       Date:  2022-10-01       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.